Shockwave Lithoplasty DISRUPT Trial for PAD (DISRUPT PAD 2)
Sponsor: Shockwave Medical, Inc.
A NA clinical study on Peripheral Arterial Disease, this trial is completed. The trial is conducted by Shockwave Medical, Inc. and has accumulated 9 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Feb 2020 — Jan 2021 [monthly]
Completed NA
▶ Show 4 earlier versions
-
Jun 2018 — Feb 2020 [monthly]
Completed NA
-
May 2018 — Jun 2018 [monthly]
Completed NA
-
Feb 2017 — May 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting NA
First recorded
Jun 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Shockwave Medical, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .